The bathing-suit distribution pattern shown as A — erythematous scaly patches in sun-protected areas (buttocks, breasts, hips, lower abdomen, medial thighs) — is the hallmark of early mycosis fungoides and corresponds to TNMB stage IA-IB (patch stage). This represents the earliest clinical manifestation of the disease, often misdiagnosed as eczema or psoriasis for 4–6 years before correct diagnosis. The histopathology (atypical cerebriform lymphocytes, epidermotropism, Pautrier microabscesses) and immunophenotype (CD3+ CD4+ CD8− CD45RO+ with CD7 loss) confirm CTCL. Stage IA-IB has excellent prognosis (>95% 5-year survival) and is managed with skin-directed therapy (topical corticosteroids, nitrogen mustard, PUVA, NBUVB).
Bolognia Dermatology 5e Ch 120; WHO-EORTC CTCL classification 2018; ISCL/EORTC 2007 TNMB staging
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.